Wound VAC therapy creates subatmospheric pressure that accelerates foot wound granulation — but the one factor that determines whether a patient will respond to VAC therapy is routinely overlooked until after the device is applied. Call (810) 206-1402 — expert podiatric care across Michigan.
Wound VAC therapy — formally called negative pressure wound therapy (NPWT) or vacuum-assisted closure — applies controlled sub-atmospheric pressure to a wound bed through a foam or gauze dressing sealed with an occlusive film and connected to a portable pump. In foot and ankle wounds, NPWT accelerates granulation tissue formation, reduces wound edema and exudate, draws wound edges together, and removes inhibitory proteases from the wound environment. It is most commonly used in diabetic foot ulcers after surgical debridement, post-partial foot amputation wounds, exposed bone or tendon requiring coverage before definitive reconstruction, and complex surgical wound dehiscences. NPWT does not heal wounds independently — it prepares the wound bed for definitive closure, graft, or flap coverage.
Wound VAC Indications and Settings for Foot Wounds
Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
| Indication | Wound Type | Pressure Setting | Foam Type | Expected Outcome |
|---|---|---|---|---|
| Post-debridement DFU / partial foot amputation wound | Open wound after surgical removal of infected tissue; exposed tendon or bone common | -75 to -125 mmHg continuous; reduce to -75 mmHg if pain or fragile tissue | Black polyurethane foam (standard); white polyvinyl alcohol foam if exposed vessels or fragile tissue | Granulation tissue formation over exposed structures in 2-4 weeks; prepares wound for split-thickness skin graft |
| Post-ray resection amputation wound | Open wound after 1st or 5th ray resection; bone stump present | -125 mmHg continuous or intermittent; intermittent improves granulation rate in some studies | Black foam; fill dead space with additional foam layers; avoid bridging | Wound contraction and bed preparation; reduces time to definitive closure vs. wet-to-dry dressing |
| Diabetic heel ulcer with exposed calcaneus | Deep heel wound; bone visible; high amputation risk location | -75 to -100 mmHg; avoid high pressure over calcaneus to prevent bone erosion | White foam (less adherent to bone); silver-impregnated foam if biofilm concern | Coverage of exposed calcaneus with granulation tissue; definitive closure with STSG or flap |
| Post-Charcot reconstruction wound management | Complex surgical wound; high edema; significant dead space | -125 mmHg; change every 48-72 hours | Black foam; obliterate all dead space; may use instillation NPWT (NPWTi) for deep infection | Edema control; wound edge approximation; dehiscence management |
| Surgical wound dehiscence | Post-operative wound breakdown after bunion, fusion, or fracture surgery | -75 to -125 mmHg based on depth and tissue quality | White foam for shallow dehiscence; black foam for deep dehiscence | Secondary intention healing with edge approximation; reduces time vs. daily dressing changes |
Wound VAC Contraindications and Precautions
| Contraindication / Precaution | Reason | Alternative |
|---|---|---|
| Untreated osteomyelitis | NPWT does not treat bone infection; seals infection in wound; may spread under suction | Surgical debridement and antibiotics first; NPWT after infection controlled |
| Necrotic tissue or eschar present | NPWT does not debride necrotic tissue; foam contacts necrotic tissue without promoting granulation | Sharp debridement to viable tissue before NPWT application |
| Exposed blood vessels or anastomosis | Suction pressure may cause vessel rupture or disruption of surgical anastomosis | White (PVA) foam over vessels; reduce pressure; consider alternative dressing near anastomosis |
| Malignancy in wound bed | NPWT stimulates cellular proliferation which may accelerate tumor growth | Palliative wound care; consult oncology before use near any suspected malignant wound |
| Critical limb ischemia without revascularization | Adequate perfusion required for granulation tissue to form; NPWT is ineffective without blood flow | Vascular assessment and revascularization before NPWT; NPWT after successful revascularization |
At Balance Foot & Ankle in Howell and Bloomfield Hills, wound VAC therapy is applied to post-debridement diabetic foot wounds and post-partial foot amputation sites to accelerate granulation tissue formation over exposed bone and tendon — with the goal of preparing the wound bed for definitive split-thickness skin graft or primary closure within 2-4 weeks. Call (810) 206-1402.
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Doctor Answer
What is wound VAC therapy and when is it used on foot wounds?
Wound VAC (vacuum-assisted closure) therapy applies controlled negative pressure to a wound through a sealed foam dressing connected to a suction device, stimulating granulation tissue growth, reducing edema, and removing wound exudate to accelerate healing. It is used for complex diabetic foot ulcers, post-surgical wounds, and large soft tissue defects. Dr. Tom Biernacki at Balance Foot & Ankle uses wound VAC therapy as part of an advanced wound care protocol to achieve healing in difficult foot wounds that have not responded to conventional dressings.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.